Assessment of Maternal and Perinatal Morbidity and Mortality in Vaginal and Cesarean Delivery
NCT ID: NCT03666078
Last Updated: 2019-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-07-15
2019-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Practice of Assisted Vaginal Birth in Egypt
NCT07308977
Digital Cervical and Cesarean Section
NCT03392077
Risk Factors for Primary Cesarean Section in Egypt
NCT03905980
Ultrasonography for Fluid Assessment in Parturients With Preeclampsia Undergoing Cesarean Section
NCT04370847
Knowledge, Attitudes, and Practices of Operative Vaginal Birth Among Obstetric Providers in Egypt
NCT06502119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Study Setting: Ain Shams maternity hospital
* Study Period: 6 months
* Study Population: in this prospective study, all women who deliver vaginally and by cesarean section at Ain Shams maternity hospital will be included.
* Sampling Method: All of the pregnant women who will deliver vaginally and all of pregnant women who will deliver by cesarean sections in the labor delivery room at Ain Shams University Maternity Hospital on a fixed day and by a fixed team over a period of 6 months
* Sample Size: all pregnant women who will deliver at Ain Shams maternity hospital.
* Inclusion criteria :
* All of the patients who will deliver vaginally
* All of the patients who will deliver by cesarean sections.
* Exclusion criteria: no exclusion criteria, all women who will attend for delivery will be included.
* Ethical Considerations: the study objectives will be briefly and clearly described to all participants and an oral consent will be obtained from all patients.
* Study Procedures :
In all selected cases the following will be recorded:
Parameters of maternal morbidity:
1. ICU admission due to the complication of delivery.
2. Need for advanced surgery (int. iliac ligation -hysterectomy -or due to the injury of pelvic organs).
3. Febrile morbidity temp \>38C on two or more occasion within 48h of delivery.
4. Postpartum hemorrhage (blood loss 500cc in VD and 1liter in C\\S).
5. Wound infection.
6. Late complications e.g. (D.V.T-puerperal sepsis and hematoma).
7. Need for blood transfusion post labor
8. Maternal mortality.
Parameters of fetal morbidity:
1. Intracranial hemorrhage as compilations of delivery.
2. Neonatal ICU admission as compilations of delivery
3. Fracture (Femur, ribs, and humorous)
4. Meconium aspiration.
5. Erb's palsy.
6. APGARscore1-5.
7. Need for intubation during resuscitation.
* Statistical analysis The patient will be subdivided into 4 groups, normal VD, instrumental VD, emergency C\\S, and elective C\\S The data has been collected in analytical sheet tabulated and statistical analysis using the following tests
1- T-test. 2- Chi-square test. 3- Fisher exact test
Statistical package :
data analysis will be performed by SPSS 16.0 using descriptive statistics tools, including mean, standard deviation and figures.A t-test will be used to compare mean values of the two groups .P-values, smaller than 0.05, were considered statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal vaginal delivery
No interventions assigned to this group
assisted vaginal delivery
No interventions assigned to this group
elective cesarean delivery
cesarean delivery
women delivered by cesarean section
emergency cesarean delivery
cesarean delivery
women delivered by cesarean section
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cesarean delivery
women delivered by cesarean section
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All of the patients who will deliver by cesarean sections.
18 Years
48 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alzahraa Ismail Ragheb Goda
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alzahraa Ismail Ragheb Goda
resident of obstetrics and gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamer F Borg, professor
Role: PRINCIPAL_INVESTIGATOR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams maternity hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
zahra2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.